PLUS THERAPEUTICS, INC. — All Filings
1,002 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001140361-25-028381 | Aug 1, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-021367 | Jul 29, 2025 | — |
| RW | RW | 0001193125-25-165419 | Jul 25, 2025 | — |
| ARS | ARS | 0001140361-25-026612 | Jul 21, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001140361-25-026611 | Jul 21, 2025 | Aug 7, 2025 |
| 8-K | 8-K | 0001193125-25-161239 | Jul 18, 2025 | Jul 16, 2025 |
| PRE 14A | PRE 14A | 0001140361-25-025650 | Jul 11, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-057808 | Jun 25, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-144289 | Jun 23, 2025 | — |
| RW | RW | 0001193125-25-144654 | Jun 23, 2025 | — |
| EFFECT | — | 9999999995-25-002000 | Jun 23, 2025 | — |
| S-1/A | S-1/A | 0001193125-25-142935 | Jun 20, 2025 | — |
| 8-K | 8-K | 0001193125-25-143665 | Jun 20, 2025 | Jun 17, 2025 |
| S-1 | S-1 | 0001193125-25-142215 | Jun 18, 2025 | — |
| CORRESP | — | 0001193125-25-142216 | Jun 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-142093 | Jun 17, 2025 | — |
| UPLOAD | — | 0000000000-25-006276 | Jun 13, 2025 | — |
| DRS | — | 0000950123-25-005986 | Jun 9, 2025 | — |
| 8-K | 8-K | 0001193125-25-137089 | Jun 6, 2025 | Jun 3, 2025 |
| 10-Q | 10-Q | 0000950170-25-079738 | May 30, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-079749 | May 30, 2025 | — |
| 8-K | 8-K | 0001193125-25-125860 | May 23, 2025 | May 21, 2025 |
| SCHEDULE 13G | — | 0001213900-25-046800 | May 22, 2025 | — |
| 8-K | 8-K | 0000950170-25-074374 | May 19, 2025 | May 16, 2025 |
| NT 10-Q | NT 10-Q | 0000950170-25-072596 | May 15, 2025 | Mar 31, 2025 |
| 144 | — | 0001972490-25-000004 | May 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-062742 | May 2, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-061484 | May 1, 2025 | — |
| 10-K/A | 10-K/A | 0000950170-25-061028 | Apr 30, 2025 | Dec 31, 2024 |
| S-3/A | S-3/A | 0001193125-25-091456 | Apr 23, 2025 | — |
| 424B3 | 424B3 | 0000950170-25-055884 | Apr 18, 2025 | — |
| 8-K | 8-K | 0000950170-25-055883 | Apr 18, 2025 | — |
| UPLOAD | — | 0000000000-25-003866 | Apr 11, 2025 | — |
| POS AM | POS AM | 0001193125-25-079109 | Apr 11, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-013256 | Apr 10, 2025 | May 2, 2025 |
| S-3 | S-3 | 0001193125-25-073481 | Apr 4, 2025 | — |
| CORRESP | — | 0001193125-25-070569 | Apr 1, 2025 | — |
| PRER14A | — | 0001140361-25-011649 | Apr 1, 2025 | — |
| 10-K | 10-K | 0000950170-25-047698 | Mar 31, 2025 | Dec 31, 2024 |
| RW | RW | 0001140361-25-011284 | Mar 31, 2025 | — |
| 8-K | 8-K | 0000950170-25-046110 | Mar 27, 2025 | — |
| UPLOAD | — | 0000000000-25-003134 | Mar 24, 2025 | — |
| SCHEDULE 13G | — | 0001079973-25-000412 | Mar 18, 2025 | — |
| PRE 14A | PRE 14A | 0001140361-25-008857 | Mar 14, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-050395 | Mar 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-050390 | Mar 10, 2025 | Mar 7, 2025 |
| 8-K | 8-K | 0001193125-25-045305 | Mar 4, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-045309 | Mar 4, 2025 | — |
| 4 | 4 | 0000950170-25-024343 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | 4 | 0000950170-25-024344 | Feb 20, 2025 | Feb 18, 2025 |